PRKAA2 and glioblastoma: Interestingly, in two glioblastoma cell lines and a breast cancer cell line in which Akt was hyperactivated due to loss of PTEN, AMPK was rather resistant to activation and Thr172 phosphorylation induced by the activator A769662.